Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts.

scientific article published in August 2001

Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0008-6363(01)00306-6
P698PubMed publication ID11470468

P50authorAlfredo GrilliQ59706004
P2093author name stringR De Caterina
A Barsotti
P Di Napoli
M Felaco
R Spina
A Antonio Taccardi
P433issue2
P921main subjectsimvastatinQ670131
reperfusion injuryQ1413991
P304page(s)283-293
P577publication date2001-08-01
P1433published inCardiovascular ResearchQ4642329
P1476titleSimvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts
P478volume51

Reverse relations

cites work (P2860)
Q33263170A preliminary study of healing of diode laser versus scalpel incisions in rat oral tissue: a comparison of clinical, histological, and immunohistochemical results
Q44959320AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction
Q34116819Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx
Q35584237Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure
Q46601568Amelioration of myocarditis by statin through inhibiting cross-talk between antigen presenting cells and lymphocytes in rats
Q46795298Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats
Q44307951Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway
Q43211132Changes in PPAR gene expression and myocardial tolerance to ischaemia: relevance to pleiotropic effects of statins
Q36081210Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins
Q44687808Differential in vitro response of the human radial artery versus left internal thoracic artery to cerivastatin: implications to bypass grafting
Q46382042Donor simvastatin treatment prevents ischemia-reperfusion and acute kidney injury by preserving microvascular barrier function
Q44739752Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts
Q47632901Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue
Q38916494Effect on eNOS/NO Pathway in MIRI rats with preconditioning of GFPC from Dang Gui Si Ni decoction
Q44037878Effects of cerivastatin on vascular function of human radial and left internal thoracic arteries
Q28580295Effects of simvastatin on cardiac performance and expression of sarcoplasmic reticular calcium regulatory proteins in rat heart
Q82894640Effects of simvastatin on cardiohemodynamic responses to ischemia-reperfusion in isolated rat hearts
Q24806340Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
Q37941943Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
Q46687759Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts
Q36836771Myocardial protection in man--from research concept to clinical practice
Q34424756Netrin-1 improves post-injury cardiac function in vivo via DCC/NO-dependent preservation of mitochondrial integrity, while attenuating autophagy
Q24624234Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism
Q47880717Nitric oxide synthase in healthy and inflamed human dental pulp
Q37014196Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review
Q37522854Occult cardiotoxicity--toxic effects on cardiac ischemic tolerance
Q45241719Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
Q34515458Pharmacological approaches to preserving and restoring coronary endothelial function
Q37033172Predictors of preinterventional patency of infarct-related artery in patients with ST-segment elevation myocardial infarction: Importance of neutrophil to lymphocyte ratio and uric acid level
Q34967386Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs.
Q36836773Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
Q37445518Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease
Q47681698Role of inducible nitric oxide synthase in myocardial ischemia-reperfusion injury in sleep-deprived rats
Q53594601Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.
Q46495061Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore
Q46869160Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats
Q36953912Simvastatin inhibits central sympathetic outflow in heart failure by a nitric-oxide synthase mechanism
Q35230306Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism
Q35762325Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat
Q43215640Statins and modulation of oxidative stress.
Q37611724Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias.
Q36768488Statins as first-line therapy for acute coronary syndrome?
Q37276466Statins in the first-line therapy of acute coronary syndrome - similar to aspirin?
Q38832154Systemic and local anti-nociceptive effects of simvastatin in the rat formalin assay: Role of peroxisome proliferator-activated receptor γ and nitric oxide.
Q38228143The effects of statin medications on aerobic exercise capacity and training adaptations.
Q57225466Threshold level of low-density lipoprotein cholesterol for the short-term benefit of statin therapy in the acute phase of myocardial infarction

Search more.